Levetiracetam Stada Arzneimittel (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This interaction stabilizes neuronal firing and lowers excitability, thereby preventing the rapid, uncontrolled electrical activity that characterises seizures.

The appropriate dose of levetiracetam is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed regimen is provided here; the prescriber sets the dosage.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks and discuss these considerations with the patient before initiating therapy in pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from many traditional antiepileptics that modulate ion channels or GABA activity. It generally has a favorable interaction profile and does not require routine therapeutic drug monitoring, making it a convenient option for many patients.

Levetiracetam Stada Arzneimittel should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct heat, and ensure the container remains tightly closed.

Levetiracetam is taken orally, usually as a tablet. It can be swallowed whole with water and may be taken with or without food, according to the prescriber’s instructions.

Serious risks include severe allergic reactions, skin conditions such as Stevens‑Johnson syndrome, blood disorders like neutropenia, and psychiatric effects such as suicidal thoughts or severe depression. Patients should seek immediate medical attention if any of these occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that may significantly alter its effectiveness.